In a new article published in EMBO Mol Med we demonstrate that cardiac lymphatic clearance of fluids and immune cells may be reduced in heart failure. In a model of pressure-overload heart failure, we show that myocardial inflammation alters lymphatic gene expression, which could limit fluid drainage, while lymphatic immune attraction profiles remain intact.
-
Myocardial inflammation reduces the expression of key lymphatic barrier genes (Cldn5 and Tjp1), thereby impairing lymphatic function.
-
Newly formed lymphatic capillaries lack valves, which further compromises directional fluid transport from the heart to the draining lymph nodes.
-
Lymphatic endothelial cells upregulate immune-modulatory genes (Ccl21 and Lyve1), which may partially compensate for the reduced flow by attracting more immune cells to the lymphatics.
-
Restoring lymphatic barrier integrity and valve formation are potential new therapeutic targets to improve myocardial fluid clearance, accelerate resolution of inflammation, and slow heart failure progression.

